Clinical studies recruiting near Bremen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Klinikum Bremen Mitte · AGO Study Group · NCT05009082 A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · Novartis Pharmaceuticals · NCT07549516 Endometrial Cancer Lymphadenectomy Trial
NA · Klinikum Bremen Mitte gGmbH, Frauenklinik · Philipps University Marburg · NCT03438474 International HIT-MED Registry (I-HIT-MED)
Phase N/A · Klinikum Bremen-Mitte · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
Phase N/A · Klinikum Bremen Mitte, Prof. Hess Kinderklinik · RECORDATI GROUP · NCT04176523 PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
Phase N/A · Hämatologie/Onkologie Praxis · Women's Cancer Study Group GmbH · NCT05792150 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Local Institution - 0277 · Bristol-Myers Squibb · NCT06976216 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Evangelische Diakonissenanstalt Bremen · Goethe University · NCT02872987 TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Phase N/A · Klinikum Bremen-Ost · NovoCure Ltd. · NCT05538806 Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNS
Phase 3 · Klinikum Bremen-Mitte gGmbH · University Hospital Freiburg · NCT06830421 A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06830720 Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Le
Phase 2 · Gesundheit Nord Klinikverbund Bremen gGmbH, Klinikum Bremen- · Goethe University · NCT06648889 International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Phase 3 · Klinikum Bremen-Mitte gGmbH, Prof.-Hess-Kinderklinik,Pädiatr · University Hospital Muenster · NCT04043494 Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in A
Phase 2 · Duplicate_DIAKO Ev. Diakonie-Krankenhaus gemeinnuetzige GmbH · AbbVie · NCT04895436 Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
Phase N/A · Krankenhaus St. Joseph-Stift Bremen GmbH · Ipsen · NCT07314164 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Phase N/A · Herzzentrum-Bremen Klinikum Links der Weser · Abbott Medical Devices · NCT04761120 Therapy Optimisation for the Treatment of Hairy Cell Leukemia
Phase 2/Phase 3 · Community based hemato-oncology medical office · University of Giessen · NCT02131753 Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
Phase 3 · Hamatologische Onkologische Praxis Im Medicum · European Organisation for Research and Treatment of Cancer - · NCT05512364 A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Phase 3 · Klinikum Bremen Mitte · Mats Heyman · NCT04307576 NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations
Phase N/A · Research Site · AstraZeneca · NCT06494540 Trust in AI and Digitalization in Healthcare Across Generational Groups: A Comparative Study of Barriers and Facilitator
Phase N/A · Constructor University (formerly known as Jacobs University) · Jacobs University Bremen gGmbH · NCT07265427 Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI
NA · Klinikum Links der Weser, Innere Medizin II · Leipzig Heart Science gGmbH · NCT05786131 A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05344469 Abbott Structural Heart Device Registry
Phase N/A · Klinikum Links der Weser · Abbott Medical Devices · NCT06590467 PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Dat
Phase N/A · Research Site · AstraZeneca · NCT05573893 Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees
Phase N/A · Constructor University (formerly known as Jacobs University) · Jacobs University Bremen gGmbH · NCT06899308 Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer
Phase 2 · Hämatologische Onkologische Praxis im Medicum · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06207734 Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML
Phase 3 · DE-Bremen-KBM · Stichting Hemato-Oncologie voor Volwassenen Nederland · NCT07075016

Look up another city

Look up another condition